Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Bernardes, Emerson; Caravan, Peter; Dam, Michael van; Deuther-Conrad, Winnie; Ellis, Beverly; Furumoto, Shozo; Guillet, Benjamin; Huang, Ya-Yao; Jia, Hongmei; Laverman, Peter; Li, Zijing; Liu, Zhaofei; Lodi, Filippo; Miao, Yubin; Perk, Lars; Schirrmacher, Ralf; Vercoullie, Johnny; Yang, Hua; Yang, Min; Yang, Xing; Zhang, Junbo; Zhang, Ming-Rong; Zhu, Hua

doi:10.1186/s41181-022-00162-3

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Bernardes, E.; Caravan, P.; van Dam, M.; Deuther-Conrad, W.; Ellis, B.; Furumoto, S.; Guillet, B.; Huang, Y.-Y.; Jia, H.; Laverman, P.; Li, Z.; Liu, Z.; Lodi, F.; Miao, Y.; Perk, L.; Schirrmacher, R.; Vercoullie, J.; Yang, H.; Yang, M.; Yang, X.; Zhang, J.; Zhang, M.-R.; Zhu, H.

Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development.
Results: This commentary of highlights has resulted in 23 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals and also a contribution in relation to MRI-agents is included.
Conclusion: Trends in (radio)chemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.

Keywords: Radiopharmacy; Radiochemistry; Radiopharmaceuticals

EJNMMI Radiopharmacy and Chemistry 7(2022)1, 9
DOI: 10.1186/s41181-022-00162-3
Cited 1 times in Scopus

Permalink: https://www.hzdr.de/publications/Publ-34228